Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...

The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

The FDA approved brentuximab vedotin (Adcetris) in combination with lenalidomide (Revlimid) and rituximab for relapsed or ...

A top-ranking scientist at the National Institutes of Health, Dr. Lawrence Tabak, was forced to retire this week, multiple ...

On Monday, a federal judge temporarily averted disaster by halting the Trump administration’s plans to slash federal funding ...

Efforts by the Trump administration to drastically cut federal investments in medical research are threatening to kneecap ...

The National Institutes of Health (NIH) is the largest single source of health care research funding in the U.S. The Trump ...

With funding from the NIH earmarked by the Autism CARES Act, researchers aim to pinpoint the environmental factors that ...

After the National Institutes of Health issued an order Friday night that would dramatically reduce funding, professor ...

Michael Lauer, deputy director of the National Institutes of Health’s extramural research, will leave the agency at the end ...

President Trump last Friday slashed billions from scientific research grants — effective Monday. Trump has taken issue with ...

Cuts to administrative costs associated with NIH grants could jeopardize the economic well-being of cities dependent on ...